Teleflex Incorporated (NYSE:TFX) Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. reduced its position in Teleflex Incorporated (NYSE:TFX) by 50.5% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 22,287 shares of the medical technology company’s stock after selling 22,729 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Teleflex were worth $3,080,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in shares of Teleflex in the fourth quarter valued at approximately $29,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 100 shares during the period. Whipplewood Advisors LLC grew its stake in shares of Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock worth $32,000 after purchasing an additional 231 shares during the period. True Wealth Design LLC increased its holdings in shares of Teleflex by 62.3% in the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock valued at $48,000 after purchasing an additional 104 shares in the last quarter. Finally, IFP Advisors Inc lifted its stake in shares of Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Up 1.0%

Shares of TFX stock opened at $121.09 on Tuesday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a fifty-two week low of $118.70 and a fifty-two week high of $249.91. The firm’s 50 day moving average price is $126.61 and its two-hundred day moving average price is $151.62. The stock has a market cap of $5.35 billion, a price-to-earnings ratio of 24.07, a price-to-earnings-growth ratio of 1.73 and a beta of 1.10.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same quarter in the previous year, the business posted $3.21 EPS. The business’s quarterly revenue was down 5.0% on a year-over-year basis. On average, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.12%. The ex-dividend date was Tuesday, May 20th. Teleflex’s dividend payout ratio (DPR) is presently 42.90%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on TFX shares. Piper Sandler restated a “neutral” rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Bank of America cut Teleflex from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, Morgan Stanley cut their price target on Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a research note on Monday, May 5th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Teleflex has a consensus rating of “Hold” and an average price target of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.